GELLC

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. Spun off from General Electric in early 2023, the company operates through four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. Its pharmaceutical diagnostics business is a major developer and manufacturer of contrast media and molecular imaging agents used to enhance medical imaging procedures across oncology, cardiology, and neurology. The company is increasingly focused on precision care, leveraging its Edison digital platform to integrate artificial intelligence and data analytics into clinical workflows to improve patient outcomes and operational efficiency.